Prospective Evaluation of Patients With Uterine Cervical Cancer in Brazilian Health Institutions - The EVITA I Study

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT02671071
Recruitment Status : Recruiting
First Posted : February 2, 2016
Last Update Posted : February 23, 2017
EVA - Grupo Brasileiro de Tumores Ginecológicos
Roche Pharma AG
Information provided by (Responsible Party):
Latin American Cooperative Oncology Group

No Study Results Posted on for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : December 2017
  Estimated Study Completion Date : November 2019